WHO / Anna Fahrion
© Credits

Supporting countries in their cysticercosis control efforts

WHO has been asked by countries affected with cysticercosis, to support their efforts in controlling the parasite and improving the clinical management of patients with neurocysticercosis.   

Donation of taenicides

The efforts in controlling the disease are mainly aimed at breaking the cycle of active transmission of the parasite. An important component of this strategy is the treatment of patients that harbor the tapeworm Taenia solium. This is most often undertaken by implementing preventive chemotherapy (mass drug administration or MDA) to reach all the eligible population. The most effective drugs at a single dose are praziquantel and niclosamide.  However, until now, these drugs were not easily available in many countries wishing to control the disease.  Under the umbrella of universal health coverage, and with the aim of providing access to quality medicines, WHO has negotiated with Bayer the donation of these two drugs which are now available for the control of T. solium through the WHO.

 

Identification of endemic areas (mapping)

Cysticercosis is a focal disease, affecting the poorest communities in which basic sanitation is deficient and pigs roam free. One of the first steps to control the disease is to identify those communities or endemic areas where control measures need to be implemented. WHO is assisting countries by providing protocols for mapping (identifying the endemic or high risk areas), as well as assisting countries such as Cambodia in training of diagnostic techniques that can be used for mapping.

 

 

30%

Neurocysticercosis is estimated to cause 30% of all epilepsy cases in T. solium endemic countries

Learn more

2.8 million

DALYs

According to WHO FERG, T. solium is a leading cause of deaths from food-borne diseases.

Learn more

One Health

Cross-sectorial collaboration is key to successfully control T. solium infections.

Learn more

Relevant publications

All →

Related activities

News

Questions and Answers

Contact

Dr. Bernadette Abela-Ridder
Technical officer